Newsroom Careers Contact Us
WORLDWIDE
Explore our offices worldwide
READ MORE
Malaysia
USA
Uzbekistan
Home
About Us
Products
R&D
Manufacturing
Partnership
NEWSROOM CAREERS CONTACT US

Newsroom

Explore Novugen Pharma's latest news and happenings.

05 MAR 2024

Novugen Secures First-to-File Status and Successful Resolution for Trametinib in the U.S.

Read More
05 MAR 2024

Malaysia’s First Locally Made Oncology Product for Export to The U.S., Dispatched

Read More
04 DEC 2023

Latest HALAL Certifications | 4th December 2023

Read More
19 OCT 2023

Novugen Received USFDA Approval for Oncology Manufacturing Facility

Read More
09 NOV 2023

Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg

Read More
19 OCT 2023

Novugen Received USFDA Approval for Oncology Manufacturing Facility

Read More
24 AUG 2023

Novugen Oncology FIRST Batch of Delivery-Genessa (Gefitinib) 250mg

Read More
24 AUG 2023

Novugen in U.S. Drugstore Management Magazine

Read More
23 AUG 2023

ANDA Approval for Sunitinib

Read More
21 AUG 2023

Novugen in Caring News, Jul – Sep 2023 Issue

Read More
12 AUG 2023

NACDS Total Store Expo 2023 San Diego, California, U.S.A.

Read More
9 AUG 2023

NPRA Approval for Novugen Products

Read More
5 AUG 2023

MIDA MITI Day 2023

Read More
1 AUG 2023

Industry Visit by Biomedical Science Students from City University Malaysia

Read More
18 JULY 2023

Human Resources Online Suite Talk by Rahil Mahmood

Read More
17 JULY 2023

Official Launch of Oncogen Pharma Pakistan

Read More
16 JUNE 2023

National Heart Association of Malaysia (NHAM) Congress 2023

Read More
13 JUNE 2023

Launch of Novtor Rosuvastatin

Read More
29 MAY 2023

Novugen's First Halal Certified Products

Read More
18 MAY 2023

Launch of Dapiga

Read More
2 MAY 2023

Novugen's 8-year Anniversary

Read More
26 MAY 2022

Announcement of Company Name Change

Read More
15 MARCH 2022

Novugen 1st International Cardiometabolic and Urogynecology Summit (NICUS)

Read More
15 MARCH 2022

Official Product Launch and Distribution Partner Zuellig Pharma

Read More
28 JANUARY 2022

Novugen Oncology Received the First ANDA Approval for Abiraterone 250mg and 500mg Tablets

Read More
11 november 2021

Novugen Welcomes Deputy Chief Executive Officer of MIDA

Read More
10 AUGUST 2021

Pioneering Novugen Pharma Vision in North America

Read More
30 JULY 2021

Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand

Read More
1 JULY 2021

Novugen Oncology Becoming the Largest and Fastest Growing Pharmaceutical Company in ASEAN by 2025

Read More
14 JUNE 2021

Novugen Oncology & Brightgene Bio-Medical Technology Announce Strategic Partnership to Enter U.S.A Pharma Market

Read More
18 MARCH 2021

Visit by The Deputy Minister of International Trade and Industry (MITI) and The Deputy Chief Executive Officer II of MIDA

Read More
14 JANUARY 2016

Novugen Oncology Launches ASEAN’s First Oncology API R&D Centre

Read More

E-Newsletter

MARCH 2022

Inaugural Issue

Read More
QUICK LINK

Contact Us

Contact our team for media inquiries

CONTACT US
© Copyright 2023. Novugen Pharma
Privacy Centre Terms of Use